Srivastava, S. K., Watkins, T., Quan, D. N., Sharma, S., Scales, D., Dacey, M., … Rosenbaum, J. T. (2022). A phase 2 randomized controlled trial of the Janus Kinase (JAK) inhibitor filgotinib in patients with noninfectious uveitis. In INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (Vol. 63).

Srivastava, Sunil K., Tim Watkins, Dong Nguyen Quan, Sumit Sharma, David Scales, Mark Dacey, Rajiv E. Shah, et al. “A phase 2 randomized controlled trial of the Janus Kinase (JAK) inhibitor filgotinib in patients with noninfectious uveitis.” In INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, Vol. 63, 2022.

Srivastava SK, Watkins T, Quan DN, Sharma S, Scales D, Dacey M, et al. A phase 2 randomized controlled trial of the Janus Kinase (JAK) inhibitor filgotinib in patients with noninfectious uveitis. In: INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE. 2022.

Srivastava, Sunil K., et al. “A phase 2 randomized controlled trial of the Janus Kinase (JAK) inhibitor filgotinib in patients with noninfectious uveitis.” INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, vol. 63, no. 7, 2022.

Srivastava SK, Watkins T, Quan DN, Sharma S, Scales D, Dacey M, Shah RE, Chu D, Grewal DS, Faia L, Suhler EB, Genovese M, Guo Y, Barchuk W, Dick AD, Rosenbaum JT. A phase 2 randomized controlled trial of the Janus Kinase (JAK) inhibitor filgotinib in patients with noninfectious uveitis. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE. 2022.